Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$204.13 - $302.4 $5.63 Million - $8.35 Million
-27,600 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$255.51 - $362.11 $7.05 Million - $9.99 Million
27,600 New
27,600 $7.84 Million
Q1 2021

May 17, 2021

SELL
$249.67 - $299.48 $8.24 Million - $9.88 Million
-33,000 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$175.56 - $226.45 $5.79 Million - $7.47 Million
33,000 New
33,000 $7.47 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.56B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Sg3 Management, LLC Portfolio

Follow Sg3 Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg3 Management, LLC with notifications on news.